Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)

Go to Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island) Website

$26.42

(%)
Live
Previous Close

$26.42

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion. RayzeBio shares gained 100% to $61.38 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers ARB IOT Group Limited (NASDAQ: ARBB) shares rose 270% to $3.4850 after gaining around 18% on Friday. IMAC Holdings, Inc. (NASDAQ: BACK) shares jumped 108% to $5.05 after jumping 53% on Friday. Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) jumped 75% to $2.0988 after the company announced 95% accuracy results for HYLA blood sensor. Gracell Biotechnologies Inc. (NASDAQ: GRCL) shares gained 60.3% to $9.92 after AstraZeneca announced plans to buy Gracell Biotechnologies for up to $1.2 billion. Science 37 Holdings, Inc. (NASDAQ: SNCE) jumped 52% to $6.62. Science 37 Holdings got notification from Nasdaq indicating the company regained compliance with minimum closing bid price requirement for continued listing. Volcon, Inc. (NASDAQ: VLCN) rose 49.8% to $0.1483 after jumping around 24% on Friday. Sight Sciences, Inc. (NASDAQ: SGHT) gained 48.9% to $5.42. AERWINS Technologies Inc.(NASDAQ: AWIN) gained 36.4% to $0.1637 after the company entered into a letter of intent to form an entity with Helicopter Technology. The company will own 70% and Helicopter Technology will own 30%. SCWorx Corp. (NASDAQ: WORX) rose 32% to $2.3349 after the company announced that it signed a definitive agreement and plan of merger with American Environmental Partners. 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) gained 30% to $1.1750 after the company announced IRB approval of its Phase IIA clinical study ...

Related tickers: VRNA, SGHT, NDRA, VLCN, ENLV, SNCE, HOLI, MIST, PSNY, SSYS, NIO, BACK, GCI, NEOV, STBX, VRM, KNW, ONCT, GRCL, AWIN, WORX, ZIM, ZJYL, FUSN, ADEX, ARBB, AAOI, DERM, TUYA, SXTP, GCT, IINN, TURB, UP, NXTP, RYZB, FPAY, CVRX, BTCT, GMBL, ABSI, LDTC, ASST, SNTG, BNZI.

Read Full Article
Trending Tickers

Please sign in to view